ENDOMETRIAL SEROUS ADENOCARCINOMA
Clinical trials for ENDOMETRIAL SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: three-drug combos tested in major trial
Disease control OngoingThis study tested three different drug combinations in 349 people with advanced (stage III or IV) or recurrent endometrial cancer. The goal was to see which combination worked best at stopping the cancer from growing or spreading. Participants received either paclitaxel/carboplat…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:52 UTC
-
New hope for recurrent endometrial cancer: drug cocktails tested
Disease control OngoingThis study tests several drug combinations in women with endometrial cancer that has returned or not responded to treatment. The drugs work by blocking cancer growth enzymes or helping the immune system attack tumors. The goal is to see if these combinations can slow or stop the …
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
New drug combo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase study tests a new drug (MLN0128) combined with bevacizumab in 50 adults with recurrent glioblastoma or other advanced solid tumors. The goal is to find the safest dose and understand side effects. This is not a cure, but aims to control tumor growth.
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC
-
New scan and dye combo may spot hidden cancer in lymph nodes
Diagnosis OngoingThis study looks at whether combining a special scan (PET/CT) with a dye that highlights lymph nodes can better detect cancer spread in women with high-risk endometrial cancer. About 100 women scheduled for surgery will get both tests before their operation. The goal is to see if…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 16, 2026 22:52 UTC
-
New drug triapine tested in uterine cancer patients before surgery
Knowledge-focused OngoingThis early-phase trial tests the drug triapine in 12 people with a rare type of uterine cancer (serous adenocarcinoma). Participants receive one dose of triapine before their scheduled hysterectomy. Researchers then examine the removed tumor tissue to see if the drug affects canc…
Matched conditions: ENDOMETRIAL SEROUS ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:56 UTC